US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedView

  • ID: 3960403
  • Report
  • Region: United States
  • 58 pages
  • iData Research
1 of 5

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost. The U.S. diabetes monitoring, treatment and drug delivery market increased in value in 2016 and growth is expected to persist over the forecast period.

Growth will be driven by the increasing prevalence of diabetes in the U.S. and technological advancements made in certain segments, particularly insulin pumps and continuous glucose monitoring (CGM). Limitations to market growth include pricing pressure due to recent CMS reimbursement changes and the negative impact on the overall blood glucose monitoring market. The recent influx of low-price competitors in the blood glucose test strip segment has also placed downward pressure on prices and resulted in market value contractions despite the growing volume and increasing number of diabetics testing their blood glucose levels.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
Table Of Contents I
List Of Figures Iii
List Of Charts V
Executive Summary
U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Disease Overview
2.1 Introduction
2.1.1 Types Of Diabetes
2.1.2 Diabetes Complications
2.1.3 Risk Factors Associated With Type 1 And Type 2 Diabetes
2.1.4 Signs And Symptoms
2.1.5 Diabetes Monitoring
2.1.6 Treatment
2.1.7 Drug Delivery Systems
U.S. Diabetes Monitoring, Treatment And Drug Delivery Market Overview
3.1 Market Overview
3.2 Trend Analysis
3.3 Drivers And Limiters
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 Competitive Market Share Analysis
3.5 Mergers And Acquisitions
Abbreviations
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott
  • Becton Dickinson
  • Eli Lilly
  • Johnson & Johnson
  • Nova Biomedical
  • Roche
  • MORE
The full report suite on the U.S. market for diabetes monitoring, treatment and drug delivery includes blood glucose meters, blood glucose test strips, lancets and lancing devices, continuous glucose monitoring (CGM), insulin, inulin pens, insulin syringes and insulin pumps. Sanofi and Novo Nordisk recently launched next-generation insulin products: insulin glargine U-300 (Toujeo®) and insulin degludec (Tresiba®), respectively. Both of these insulin analogs are “ultra-long-acting” and have an average duration of 24 to 36 hours, which means that patients will only be required to perform once-daily injections. Novo Nordisk is currently developing Ryzodeg®, a premixed insulin analog comprising insulin degludec (Tresiba®) and insulin aspart (NovoLog®), in addition to an “ultra-rapid-acting” insulin analog, which are both expected to be launched during the forecast period. The insulin-dependent patient population is expected to transition to next-generation insulin products and will contribute to the growth of the insulin market and associated insulin delivery markets.
Note: Product cover images may vary from those shown
5 of 5
Sanofi
Novo Nordisk
Eli Lilly
Medtronic
Johnson & Johnson
Becton Dickinson
Abbott
Roche
DexCom
Ascensia
Insulet
Trividia Health
Tandem
Nova Biomedical
Valeritas
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll